Lactococcus lactis type III-A CRISPR-Cas system cleaves bacteriophage RNA

RNA Biol. 2019 Apr;16(4):461-468. doi: 10.1080/15476286.2018.1502589. Epub 2018 Oct 2.

Abstract

CRISPR-Cas defends microbial cells against invading nucleic acids including viral genomes. Recent studies have shown that type III-A CRISPR-Cas systems target both RNA and DNA in a transcription-dependent manner. We previously found a type III-A system on a conjugative plasmid in Lactococcus lactis which provided resistance against virulent phages of the Siphoviridae family. Its naturally occurring spacers are oriented to generate crRNAs complementary to target phage mRNA, suggesting transcription-dependent targeting. Here, we show that only constructs whose spacers produce crRNAs complementary to the phage mRNA confer phage resistance in L. lactis. In vivo nucleic acid cleavage assays showed that cleavage of phage dsDNA genome was not detected within phage-infected L. lactis cells. On the other hand, Northern blots indicated that the lactococcal CRISPR-Cas cleaves phage mRNA in vivo. These results cannot exclude that single-stranded phage DNA is not being targeted, but phage DNA replication has been shown to be impaired.

Keywords: CRISPR; Phages; resistance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Base Sequence
  • CRISPR-Cas Systems / genetics*
  • DNA, Intergenic / genetics
  • DNA, Viral / genetics
  • Lactococcus lactis / genetics*
  • RNA, Viral / genetics*
  • Virus Replication / genetics

Substances

  • DNA, Intergenic
  • DNA, Viral
  • RNA, Viral

Grants and funding

This work was supported in part by the Canada Research Chairs; Natural Sciences and Engineering Research Council of Canada.